FMI analysis suggests that the future growth of the radiance-boosting skin care market will no longer be driven by optical brightening or cosmetic glow effects alone, but by clinically validated pathways that enhance cellular turnover, microcirculation, and skin light-reflection quality. The research outlook indicates that as biomarker-backed actives, tone-correcting technologies, and dermatologist-endorsed protocols gain wider adoption, the radiance-boosting skin care market will shift from occasion-based cosmetic enhancement into daily corrective regimens.